A major British trial is about to find out - after many sufferers said they'd recovered following their jab More than a million Britons are living with lingering problems after coronavirus
British scientists to explore giving long Covid patients monthly doses of vaccine
First stage of study given green light on Friday with human trials to begin in 2021
Even as Covid cases continue to climb, the Government's plan to lift all remaining restrictions in a matter of days is still on track for a single reason: the vaccine has severely weakened the link between infections, hospitalisations and deaths.
Yet, amid the optimism, another concern has cast a shadow the rising diagnoses of long Covid, the debilitating condition that leaves sufferers battling symptoms for months after being infected.
More than a million Britons are said to be living with lingering problems, from breathlessness to brain fog, and that figure could double by the end of the summer, say experts.
With no effective drug treatments yet discovered, there has been little hope for those living with the worst difficulties until now.
In a world first, British scientists are set to explore giving long Covid patients monthly doses of the Covid vaccine, in an effort to combat the chronic condition.
The first stage of the study was given the green light on Friday: later this year, 40 long Covid sufferers will be offered at least two extra jabs.
Funding has been offered by several of the major vaccine developers, and if the pilot is successful the scientists involved have been told they can recruit thousands more patients.
Speaking exclusively to The Mail on Sunday, Dr David Strain, senior clinical lecturer at the University of Exeter Medical School, who will lead the trial, says the manufacturers are interested in funding the study after early research showed that long Covid symptoms were significantly reduced after patients had a jab.

Poster Comment:
Those Brits have gone stark raving mad.